BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.57B |
| 2 |
Tesla
TSLA
|
+$781M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$657M |
| 4 |
Advanced Micro Devices
AMD
|
+$646M |
| 5 |
ExxonMobil
XOM
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.23B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$667M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$592M |
| 4 |
Broadcom
AVGO
|
+$588M |
| 5 |
Texas Instruments
TXN
|
+$524M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Financials | 6.69% |
| 3 | Consumer Discretionary | 5.99% |
| 4 | Healthcare | 5.68% |
| 5 | Industrials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Guggenheim Strategic Opportunities Fund
GOF
$2.39B
| $120K | ﹤0.01% |
10,961
+1,610
| +17% | +$18K |
|
4327
Vitesse Energy
VTS
$682M
| $120K | ﹤0.01% |
7,590
-11,268
| -60% | -$199K |
|
4328
Ironwood Pharmaceuticals
IRWD
$674M
| $120K | ﹤0.01% |
28,385
-17,258
| -38% | -$66.5K |
|
4329
ASP Isotopes
ASPI
$539M
| $119K | ﹤0.01% |
19,156
-8,500
| -31% | -$50K |
|
|
WSE
4330
Wise Group
WSE
$12.8B
| $119K | ﹤0.01% |
+10,000
| New | +$119K |
|
4331
CytomX Therapeutics
CTMX
$730M
| $119K | ﹤0.01% |
31,712
-574,563
| -95% | -$2.19M |
|
4332
Blackstone Secured Lending
BXSL
$5.83B
| $119K | ﹤0.01% |
5,000
-261,501
| -98% | -$6.25M |
|
4333
Allogene Therapeutics
ALLO
$683M
| $118K | ﹤0.01% |
56,759
-14,206
| -20% | -$31.2K |
|
|
PMTR
4334
Perimeter Acquisition Corp I
PMTR
| $118K | ﹤0.01% |
11,320
| – | – |
|
4335
Information Services Group
III
$250M
| $117K | ﹤0.01% |
28,571
-5,962
| -17% | -$24.9K |
|
4336
HBT Financial
HBT
$1.35B
| $117K | ﹤0.01% |
3,665
-952
| -21% | -$27.4K |
|
4337
Zegna
ZGN
$3.73B
| $117K | ﹤0.01% |
8,982
-4,674
| -34% | -$60.3K |
|
4338
SI-BONE Inc
SIBN
$849M
| $117K | ﹤0.01% |
7,155
-2,890
| -29% | -$41.3K |
|
|
STLN
4339
Starling Oncology, Inc. Common Stock
STLN
$638M
| $117K | ﹤0.01% |
21,461
+4,533
| +27% | +$19K |
|
4340
CALL
XPeng
XPEV
$11.3B
| $117K | ﹤0.01% |
88
| – | – |
|
4341
Talkspace
TALK
$871M
| $116K | ﹤0.01% |
22,392
-8,480
| -27% | -$44K |
|
|
BGSI
4342
Boyd Group Services
BGSI
$2.56B
| $116K | ﹤0.01% |
+1,230
| New | +$135K |
|
4343
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| $114K | ﹤0.01% |
1,382
-400,189
| -100% | -$33.1M |
|
4344
Farmers & Merchants Bancorp
FMAO
$486M
| $114K | ﹤0.01% |
3,729
+324
| +10% | +$8.95K |
|
4345
Candel Therapeutics
CADL
$865M
| $114K | ﹤0.01% |
11,046
+517
| +5% | +$3.9K |
|
4346
iShares Intermediate Government/Credit Bond ETF
GVI
$3.8B
| $113K | ﹤0.01% |
1,069
+878
| +460% | +$93.3K |
|
4347
Prospect Capital
PSEC
$1.18B
| $113K | ﹤0.01% |
48,995
-103,212
| -68% | -$254K |
|
4348
Vanguard FTSE Pacific ETF
VPL
$8.65B
| $113K | ﹤0.01% |
977
+329
| +51% | +$36.4K |
|
4349
Core Laboratories
CLB
$569M
| $113K | ﹤0.01% |
9,700
-503
| -5% | -$7.18K |
|
4350
PAR Technology
PAR
$770M
| $113K | ﹤0.01% |
6,464
-7,446
| -54% | -$107K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2026 Portfolio in Review
As of Q2 2026, BNP Paribas Financial Markets held 6,280 positions worth $289B, up 40% from $206B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets's Q2 2026 filing shows 491 new, 2,324 increased, 2,334 reduced and 375 closed positions. Its largest new stake was Honeywell Aerospace: 869,061 shares worth $192M. The largest sale was Microsoft, an estimated $2.23B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2026 buy was Honeywell Aerospace: 869,061 shares worth $192M.
- BNP Paribas Financial Markets added most to Micron Technology in Q2 2026, an estimated $2.57B increase.
- BNP Paribas Financial Markets's biggest Q2 2026 reduction was Microsoft, cutting an estimated $2.23B.
- BNP Paribas Financial Markets fully exited Coterra Energy in Q2 2026, selling an estimated $57.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $289B portfolio in Q2 2026.
- BNP Paribas Financial Markets opened 491 new positions and closed 375 in Q2 2026.
- BNP Paribas Financial Markets's portfolio value rose 40% quarter-over-quarter to $289B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.